Digital Behavioral Infrastructure for Glucagon-Like Peptide-1 Pharmacotherapy: Viewpoint on Persistence, Tolerability, and Postcessation Durability

doi:10.2196/104227

Learn more about this specific study/application/innovation directly from the authors of this article.

(opens a new window to the external site)

Published on 08.Sep.2026 in Vol 28 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/104227, first published 15.Jun.2026.

Infographic: GLP-1 therapy, habit windows, and digital support for behavior change.

Digital Behavioral Infrastructure for Glucagon-Like Peptide-1 Pharmacotherapy: Viewpoint on Persistence, Tolerability, and Postcessation Durability

Geoff Cook¹

Article Authors Cited by Tweetations Metrics

There are no citations yet available for this article according to Crossref .

Citation

Please cite as:

Cook G
Digital Behavioral Infrastructure for Glucagon-Like Peptide-1 Pharmacotherapy: Viewpoint on Persistence, Tolerability, and Postcessation Durability
J Med Internet Res 2026;28:e104227
doi: 10.2196/104227 PMID: 42709474

Export Metadata

END for: Endnote

BibTeX for: BibDesk, LaTeX

RIS for: RefMan, Procite, Endnote, RefWorks

Add this article to your Mendeley library

This paper is in the following e-collection/theme issue:

Viewpoints and Perspectives (1419) Web-based and Mobile Health Interventions (5874) Theoretical Frameworks and Concepts (560) Decision Support for Health Professionals (2261) Prescribable Digital Interventions (Digital Therapeutics) (80)

Download

Download PDF Download XML

Share Article

Share on Bluesky Share on Twitter Share on Facebook Share on LinkedIn